As of 3:37pm ET
| -0.0129 / -2.55%|
The 4 analysts offering 12-month price forecasts for Caladrius Biosciences Inc have a median target of 3.00, with a high estimate of 6.00 and a low estimate of 1.00. The median estimate represents a +509.63% increase from the last price of 0.49.
The current consensus among 4 polled investment analysts is to Hold stock in Caladrius Biosciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.